Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Fluidigm Corporation stock
Learn how to easily invest in Fluidigm Corporation stock.
Fluidigm Corporation is a diagnostics & research business based in the US. Fluidigm Corporation shares (FLDM) are listed on the NASDAQ and all prices are listed in US Dollars. Fluidigm Corporation employs 627 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Fluidigm Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – FLDM – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Fluidigm Corporation stock price (NASDAQ: FLDM)Use our graph to track the performance of FLDM stocks over time.
Fluidigm Corporation shares at a glance
|Latest market close||$2.98|
|52-week range||$3.03 - $7.51|
|50-day moving average||$4.10|
|200-day moving average||$5.43|
|Wall St. target price||$10.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.90|
Buy Fluidigm Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Fluidigm Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Fluidigm Corporation price performance over time
|1 week (2022-01-14)||-4.79%|
|1 month (2021-12-22)||-19.46%|
|3 months (2021-10-22)||-42.80%|
|6 months (2021-07-22)||-50.74%|
|1 year (2021-01-22)||-56.50%|
|2 years (2020-01-21)||-30.70%|
|3 years (2019-01-18)||8.73|
|5 years (2017-01-20)||6.6|
Is Fluidigm Corporation stock undervalued or overvalued?
Valuing Fluidigm Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Fluidigm Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Fluidigm Corporation's PEG ratio
Fluidigm Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.3. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Fluidigm Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Fluidigm Corporation financials
|Revenue TTM||$136.9 million|
|Gross profit TTM||$46.9 million|
|Return on assets TTM||-15.1%|
|Return on equity TTM||-53.98%|
|Market capitalisation||$239.4 million|
TTM: trailing 12 months
Fluidigm Corporation share dividends
We're not expecting Fluidigm Corporation to pay a dividend over the next 12 months.
Fluidigm Corporation share price volatility
Over the last 12 months, Fluidigm Corporation's shares have ranged in value from as little as $3.03 up to $7.51. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fluidigm Corporation's is 1.1652. This would suggest that Fluidigm Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Fluidigm Corporation overview
Fluidigm Corporation creates, manufactures, and markets technologies and life sciences tools worldwide. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, Hyperion tissue imager, and flow conductor; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow. , as well as Maxpar direct immune profiling assays and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs, Juno genotyping IFC, dynamic array IFCs, digital array IFCs, and Flex Six IFC; and assays and reagents, including Advanta RNA-Seq NGS library prep kits, delta gene and SNP type assays, access array target-specific primers and targeted sequencing prep primers, and targeted DNA Seq library assays. Further, the company offers single cell microfluidics that comprise C1 system, Polaris system, C1 IFCs, and Polaris IFC. Fluidigm Corporation sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations.
Fluidigm Corporation in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Frequently asked questionsWhat percentage of Fluidigm Corporation is owned by insiders or institutions?
Currently 1.905% of Fluidigm Corporation shares are held by insiders and 91.493% by institutions. How many people work for Fluidigm Corporation?
Latest data suggests 627 work at Fluidigm Corporation. When does the fiscal year end for Fluidigm Corporation?
Fluidigm Corporation's fiscal year ends in December. Where is Fluidigm Corporation based?
Fluidigm Corporation's address is: 2 Tower Place, South San Francisco, CA, United States, 94080 What is Fluidigm Corporation's ISIN number?
Fluidigm Corporation's international securities identification number is: US34385P1084 What is Fluidigm Corporation's CUSIP number?
Fluidigm Corporation's Committee on Uniform Securities Identification Procedures number is: 34385P108
More guides on Finder
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Ask an Expert